rethinkPeptides Search
Menu
Study breakdown

Acupuncture May Modulate GLP-1 and Gut Peptide Signaling for Obesity Through the Microbiota-Gut-Brain Axis

evidence
The takeaway

This narrative review proposes that acupuncture targets obesity through the same gut-brain peptide pathways as nutritional interventions, including GLP-1, short-chain fatty acids, and GPR43 signaling.

Shared targets: GLP-1, SCFAs, GPR43

The review identifies these gut-brain signaling molecules as convergence points between acupuncture mechanisms and established nutritional/pharmacological obesity interventions

What the researchers found

The review proposes an integrative framework connecting acupuncture to obesity treatment through the microbiota-gut-brain axis, identifying shared targets with dietary interventions:

- Short-chain fatty acids (SCFAs) produced by gut bacteria

- Glucagon-like peptide-1 (GLP-1) — the same peptide hormone targeted by semaglutide and other obesity drugs

- G protein-coupled receptors, particularly GPR43, which mediates SCFA and metabolic signaling

Acupuncture is proposed to improve microbial diversity, enhance gut barrier integrity, regulate nutrient-derived signaling molecules, and influence appetite control and inflammatory responses through neural, endocrine, and immune networks within the gut-brain axis.

Why it matters

As GLP-1 receptor agonists become blockbuster drugs for obesity, understanding non-pharmacological approaches that may modulate the same peptide signaling pathways is valuable. If acupuncture genuinely enhances endogenous GLP-1 release or gut peptide signaling, it could serve as a complementary therapy — potentially improving outcomes when combined with dietary modifications or reducing reliance on expensive medications.

How the study worked

This is a narrative review synthesizing published research on acupuncture's effects on gut microbiota, gut barrier function, peptide hormone signaling (particularly GLP-1), and metabolic outcomes in the context of obesity. The review draws parallels between acupuncture mechanisms and dietary/nutritional interventions that target the same pathways.

What this study cannot tell us

This is a narrative review presenting a conceptual framework rather than systematic evidence. The quality and rigor of the underlying acupuncture studies cited are variable. Direct evidence that acupuncture significantly modulates GLP-1 levels in humans is limited. The proposed mechanisms are largely speculative, drawing parallels between acupuncture effects and known nutritional pathways without definitive mechanistic proof. Sham-controlled acupuncture trials for obesity have shown mixed results.

How to read the evidence

This is a narrative review presenting a conceptual framework. It does not include new data or systematic evidence synthesis. The underlying acupuncture evidence ranges from preclinical to small clinical studies with variable quality.

When this study was published

Published in 2025, this review reflects current interest in integrating traditional medicine approaches with modern understanding of gut peptide biology and the microbiota-gut-brain axis.

The bigger picture

The gut-brain axis is increasingly recognized as central to metabolic health, and GLP-1 is its most clinically important peptide mediator. This review places acupuncture within this framework, suggesting it works through established metabolic pathways rather than mysterious mechanisms. Whether acupuncture's effects on GLP-1 and gut peptides are clinically significant compared to pharmacological GLP-1 agonists remains to be determined, but the conceptual link to established peptide biology is notable.

Questions still open

  • Does acupuncture produce measurable increases in circulating GLP-1 levels comparable to pharmacological or dietary interventions?
  • Could combining acupuncture with GLP-1 receptor agonist therapy enhance metabolic outcomes beyond either approach alone?
  • What specific acupuncture protocols and acupoints most reliably affect gut peptide signaling?

Common questions

Could acupuncture really affect the same hormones as Ozempic?
The review suggests both acupuncture and GLP-1 drugs may modulate the gut-brain axis, including GLP-1 signaling. However, the magnitude of effect is likely very different — pharmacological GLP-1 agonists produce dramatic, sustained hormone activation, while any acupuncture effect on GLP-1 would be much more subtle. Direct evidence for clinically meaningful GLP-1 modulation by acupuncture is limited.
What is the microbiota-gut-brain axis?
It's a communication network connecting gut bacteria, the intestinal lining, and the brain through hormones (like GLP-1), nerve signals (vagus nerve), and immune molecules. This axis regulates appetite, metabolism, and inflammation. Both dietary changes and, according to this review, acupuncture may influence this system to affect body weight.

Read the original research

Acupuncture and nutritional parallels in obesity: a narrative review of multi-pathway modulation of the microbiota-gut-brain axis.

Frontiers in nutrition, 12, 1610814

Citation

Ma, Kun; Wang, Feifei; Zhang, Xinying; Guo, Liangqing; Huang, Yanqin. (2025). Acupuncture and nutritional parallels in obesity: a narrative review of multi-pathway modulation of the microbiota-gut-brain axis.. Frontiers in nutrition, 12, 1610814. https://doi.org/10.3389/fnut.2025.1610814